Britain offers contingency plan to prevent API shortages

06/18/2013 | In-PharmaTechnologist.com

The U.K. Medicines and Healthcare Products Regulatory Agency, concerned about potential shortages when new rules requiring regulator certificates go into effect July 2, has said that it will allow API imports lacking such written confirmation on a case-by-case basis to ensure continued supplies. Imports should still have a valid EU good manufacturing practices certificate, and drug firms will need to have audited the API manufacturing site within the past three years.

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ